KweHealth, LLC

KweHealth is a pioneering techbio company specializing in the development of next-generation regenerative biotherapeutics. Our innovative platform enables us to manufacture clinical grade exosome therapeutics from perinatal tissues with disease modifying components. Our unique approach integrates advanced analytics and AI, enabling us to identify therapeutic targets and optimize treatment protocols. Our vision is to create a dynamic ecosystem for regenerative medicine, where innovation, patient care, and data-driven strategies converge. With applications in neurodegenerative diseases, chronic pain and beyond, we are on a mission to transform lives and set new paradigms in patient care and personalized medicine.